These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35001506)

  • 1. Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway.
    Ni WJ; Guan XM; Zeng J; Zhou H; Meng XM; Tang LQ
    J Cell Mol Med; 2022 Feb; 26(4):1144-1155. PubMed ID: 35001506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
    Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
    Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
    Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
    Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
    Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
    Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
    Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.
    Yang Z; Li J; Xiong F; Huang J; Chen C; Liu P; Huang H
    Exp Cell Res; 2016 Aug; 346(2):241-7. PubMed ID: 27292312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L; Han J; Yuan R; Xue L; Pang W
    Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase/Akt-dependent mechanism.
    Zhang X; Liang D; Lian X; Jiang Y; He H; Liang W; Zhao Y; Chi ZH
    Apoptosis; 2016 Jun; 21(6):721-36. PubMed ID: 26979714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.
    Ni WJ; Zhou H; Ding HH; Tang LQ
    J Diabetes Investig; 2020 Mar; 11(2):297-306. PubMed ID: 31336024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy.
    Chen K; Yu B; Liao J
    Mol Med; 2021 Jul; 27(1):71. PubMed ID: 34238205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway.
    Wang YY; Tang LQ; Wei W
    Eur J Pharmacol; 2018 Apr; 824():185-192. PubMed ID: 29378192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Let‑7a‑5p may participate in the pathogenesis of diabetic nephropathy through targeting HMGA2.
    Wang T; Zhu H; Yang S; Fei X
    Mol Med Rep; 2019 May; 19(5):4229-4237. PubMed ID: 30896854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models.
    Huang K; Liu W; Lan T; Xie X; Peng J; Huang J; Wang S; Shen X; Liu P; Huang H
    PLoS One; 2012; 7(8):e43874. PubMed ID: 22937115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-205-5p-Mediated MAGI1 Inhibition Attenuates the Injury Induced by Diabetic Nephropathy.
    Xiang Y; Sun M; Wu Y; Hu Y
    Pharmacology; 2024; 109(2):98-109. PubMed ID: 38325349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
    Liu W; Liu P; Tao S; Deng Y; Li X; Lan T; Zhang X; Guo F; Huang W; Chen F; Huang H; Zhou SF
    Arch Biochem Biophys; 2008 Jul; 475(2):128-34. PubMed ID: 18471986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA TUG1 inhibits the proliferation and fibrosis of mesangial cells in diabetic nephropathy via inhibiting the PI3K/AKT pathway.
    Zang XJ; Li L; Du X; Yang B; Mei CL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7519-7525. PubMed ID: 31539141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.